JP2016520133A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520133A5
JP2016520133A5 JP2016517049A JP2016517049A JP2016520133A5 JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5 JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5
Authority
JP
Japan
Prior art keywords
group
alkyl
carbon atoms
alkoxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016517049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520133A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/040286 external-priority patent/WO2014194226A2/en
Publication of JP2016520133A publication Critical patent/JP2016520133A/ja
Publication of JP2016520133A5 publication Critical patent/JP2016520133A5/ja
Pending legal-status Critical Current

Links

JP2016517049A 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物 Pending JP2016520133A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361829759P 2013-05-31 2013-05-31
US61/829,759 2013-05-31
US201361839609P 2013-06-26 2013-06-26
US61/839,609 2013-06-26
PCT/US2014/040286 WO2014194226A2 (en) 2013-05-31 2014-05-30 Methods of treatment and compositions with xanthine oxidase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034081A Division JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Publications (2)

Publication Number Publication Date
JP2016520133A JP2016520133A (ja) 2016-07-11
JP2016520133A5 true JP2016520133A5 (enExample) 2017-07-06

Family

ID=50983231

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016517049A Pending JP2016520133A (ja) 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Country Status (9)

Country Link
US (2) US20140357683A1 (enExample)
JP (2) JP2016520133A (enExample)
CN (1) CN105579037A (enExample)
CA (1) CA2913755A1 (enExample)
MX (1) MX2015016494A (enExample)
PH (1) PH12015502679A1 (enExample)
SG (2) SG10201709955PA (enExample)
TW (1) TW201536284A (enExample)
WO (1) WO2014194226A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180318246A1 (en) * 2015-10-28 2018-11-08 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of dimethyl fumarate
CN105769766B (zh) * 2016-03-24 2018-07-06 长沙佰顺生物科技有限公司 一种托匹司他纳米乳及其制备方法
JP7108384B2 (ja) * 2016-07-13 2022-07-28 日本ケミファ株式会社 2-[3-シアノ-4-(2-メチルプロポキシ)フェニル]-4-メチルチアゾール-5-カルボン酸の口腔内崩壊錠
AU2017298142B2 (en) * 2016-07-18 2021-11-11 Arthrosi Therapeutics, Inc. Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
CN113164439A (zh) 2018-12-06 2021-07-23 安索治疗公司 用于治疗或预防痛风或高尿酸血症的方法
JP2022511800A (ja) 2018-12-06 2022-02-01 アースローシ セラピューティクス,インク. 痛風または高尿酸血症を処置または予防するための化合物の結晶形態
US20220323441A1 (en) * 2019-06-04 2022-10-13 Nippon Chemiphar Co., Ltd. Therapeutic for gout or hyperuricemia
TWI901895B (zh) * 2021-06-15 2025-10-21 南韓商Lg化學股份有限公司 一種包含1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-甲酸的醫藥組成物
AR126164A1 (es) * 2021-06-17 2023-09-27 Lg Chemical Ltd Formulación compuesta para dosificación oral que comprende ácido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxílico
CN115252567A (zh) * 2022-07-08 2022-11-01 广西纯正堂制药有限公司 非布司他渗透泵缓释片及其制备方法
WO2026067357A1 (zh) * 2024-09-27 2026-04-02 上海云晟研新生物科技有限公司 托吡司特药物组合物、制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5573776A (en) 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5544163A (en) 1994-03-08 1996-08-06 Excel, Inc. Expandable telecommunications system
ES2505690T3 (es) 2002-03-28 2014-10-10 Teijin Pharma Limited Preparación sólida que contiene una forma única de cristal de un derivado de ácido tiazolcarboxílico
ATE512154T1 (de) 2004-06-14 2011-06-15 Nippon Chemiphar Co Kondensiertes pyrimidinderivat und xanthinoxidaseinhibitor
CA2621038A1 (en) 2005-10-07 2007-04-19 Astellas Pharma Inc. Triarylcarboxylic acid derivative
RU2009131454A (ru) * 2007-01-19 2011-02-27 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств
BRPI1013432B1 (pt) 2009-03-31 2019-12-17 Kissei Pharmaceutical derivado de indolizina e composição farmacêutica
CN101773498B (zh) * 2009-12-30 2012-06-20 青岛黄海制药有限责任公司 一种含有非布司他的口服缓控释制剂的制备方法
UY33455A (es) 2010-06-16 2012-01-31 Teijin Pharma Ltd Tableta con núcleo recubierto de liberación controlada
EP2582812B1 (en) * 2010-06-16 2018-01-24 Takeda Pharmaceuticals U.S.A., Inc. Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
CN102641255A (zh) * 2012-05-08 2012-08-22 南方医科大学 一种治疗痛风的非布索坦渗透泵控释片及其制备方法

Similar Documents

Publication Publication Date Title
RU2011143741A (ru) Производное индолизина и его применение в медицинских целях
JP2016512520A5 (enExample)
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
JP2011513305A5 (enExample)
JP2016515561A5 (enExample)
JP2013531029A5 (enExample)
JP2013528655A5 (enExample)
JP2016518437A5 (enExample)
JP2012508252A5 (enExample)
JP2017537940A5 (enExample)
JP2014504622A5 (enExample)
JP2012184234A5 (enExample)
JP2012041349A5 (enExample)
JP2015522650A5 (enExample)
ZA201802312B (en) A group of compounds used for the treatment or prevention of hyperuricemia or gout
JP2013508288A5 (enExample)
JP2018533593A5 (enExample)
JP2016507575A5 (enExample)
JP2013063968A5 (enExample)
MX339829B (es) Metodo para estabilizar daño de articulacion en sujetos utilizando inhibidores de xantina oxidoreductasa.
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
JP2015521156A5 (enExample)
RU2015135824A (ru) Бициклические соединения пиримидона в качестве ингибиторов lp-pla2
JP2017510660A5 (enExample)
RU2016142611A (ru) Пролекарственные средства ингибиторов обратной транскриптазы вич